NZ231938A - Use of blackcurrant lipid in a dietetic or pharmaceutical composition to prevent cell adhesion - Google Patents

Use of blackcurrant lipid in a dietetic or pharmaceutical composition to prevent cell adhesion

Info

Publication number
NZ231938A
NZ231938A NZ231938A NZ23193889A NZ231938A NZ 231938 A NZ231938 A NZ 231938A NZ 231938 A NZ231938 A NZ 231938A NZ 23193889 A NZ23193889 A NZ 23193889A NZ 231938 A NZ231938 A NZ 231938A
Authority
NZ
New Zealand
Prior art keywords
hpc
acid
lipids
dhla
fatty acids
Prior art date
Application number
NZ231938A
Other languages
English (en)
Inventor
Gayle Crozier-Willi
Mathilde Fleith
Michael Buchanan
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of NZ231938A publication Critical patent/NZ231938A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Steroid Compounds (AREA)
NZ231938A 1988-12-23 1989-12-21 Use of blackcurrant lipid in a dietetic or pharmaceutical composition to prevent cell adhesion NZ231938A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4790/88A CH676909A5 (enExample) 1988-12-23 1988-12-23

Publications (1)

Publication Number Publication Date
NZ231938A true NZ231938A (en) 1992-07-28

Family

ID=4282587

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ231938A NZ231938A (en) 1988-12-23 1989-12-21 Use of blackcurrant lipid in a dietetic or pharmaceutical composition to prevent cell adhesion

Country Status (14)

Country Link
US (1) US5141958A (enExample)
EP (1) EP0374591B1 (enExample)
JP (1) JP3284132B2 (enExample)
AT (1) ATE81985T1 (enExample)
AU (1) AU622500B2 (enExample)
CA (1) CA2004332C (enExample)
CH (1) CH676909A5 (enExample)
DE (1) DE68903378T2 (enExample)
ES (1) ES2045363T3 (enExample)
IE (1) IE62603B1 (enExample)
NO (1) NO895183L (enExample)
NZ (1) NZ231938A (enExample)
PT (1) PT92690B (enExample)
ZA (1) ZA899632B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994392A (en) * 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
JP2782443B2 (ja) * 1988-12-26 1998-07-30 將純 吉原 抗エイズウィルス剤
US5354269A (en) * 1991-12-20 1994-10-11 Fibrogenex, Inc. Method for treating cancer resections
EP0711503A3 (en) * 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
EP0914116B1 (en) * 1996-05-22 2000-10-11 Protarga Inc. Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
US6440448B1 (en) 1998-03-16 2002-08-27 Joseph Intelisano Food supplement/herbal composition for health enhancement
US7235583B1 (en) * 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
AU4073800A (en) * 1999-04-05 2000-10-23 Wake Forest University Oxidized polyunsaturated fatty acids having anti-proliferative activity and methods of use
CA2304906A1 (en) * 2000-04-07 2001-10-07 1411198 Ontario Limited 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
AU2002305099A1 (en) * 2001-03-23 2002-10-08 Protarga, Inc. Fatty alcohol drug conjugates
AU2002303164A1 (en) * 2001-03-23 2002-10-08 Protarga, Inc. Fatty amine drug conjugates
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
CN103637102A (zh) * 2009-05-29 2014-03-19 吉布控股（纳尔逊）有限公司 补充剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490631A1 (fr) * 1980-09-24 1982-03-26 Roussel Uclaf Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
ATE24266T1 (de) * 1982-04-16 1987-01-15 Nestle Sa Lipidhaltige zusammensetzung fuer die orale, enterale oder parenterale ernaehrung.
IE54795B1 (en) * 1982-04-29 1990-02-14 Efamol Ltd Pharmaceutical composition
CH673223A5 (enExample) * 1987-10-16 1990-02-28 Nestle Sa

Also Published As

Publication number Publication date
IE62603B1 (en) 1995-02-22
PT92690A (pt) 1990-06-29
US5141958A (en) 1992-08-25
ATE81985T1 (de) 1992-11-15
JP3284132B2 (ja) 2002-05-20
JPH02221228A (ja) 1990-09-04
ES2045363T3 (es) 1994-01-16
DE68903378D1 (de) 1992-12-10
AU622500B2 (en) 1992-04-09
EP0374591A1 (fr) 1990-06-27
AU4554789A (en) 1990-06-28
NO895183D0 (no) 1989-12-21
PT92690B (pt) 1995-12-29
DE68903378T2 (de) 1993-05-06
IE893878L (en) 1990-06-23
CA2004332C (en) 2000-07-18
EP0374591B1 (fr) 1992-11-04
CA2004332A1 (en) 1990-06-23
NO895183L (no) 1990-06-25
ZA899632B (en) 1990-09-26
CH676909A5 (enExample) 1991-03-28

Similar Documents

Publication Publication Date Title
AU622500B2 (en) Blackcurrant lipid for inhibitation of cell adhesion
Nieto et al. Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis
Greenfield et al. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis
von Schacky et al. Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans.
US20060052446A1 (en) Fatty acid-containing compositions and methods for the treatment of cytokine mediated disorders
EP0440307B1 (en) Pharmaceutical and dietary composition
AU2009309237B2 (en) Fatty acids for use as a medicament
Bhattacharya et al. Effect of fish oil on bone mineral density in aging C57BL/6 female mice
JPS61215322A (ja) γ‐リノレン酸またはジホモ‐γ‐リノレン酸の使用方法
GB2223943A (en) Oral disage forms of omega-3 polyunsaturated acids
SK18162002A3 (sk) Terapeutické kombinácie mastných kyselín
JP2002534445A (ja) 血中コレステロール及び／又は血中トリグリセリドの低下方法
US5234952A (en) Reduction of thrombogenicity with lipids of blackcurrant seed
Yamazaki et al. Changes in fatty acid composition in rat blood and organs after infusion of docosahexaenoic acid ethyl ester
HK8294A (en) Pharmaceutical and dietary compositions containing linolenic acids for the treatment of benign prostatic hypertrophy
JPH04290821A (ja) 液体栄養副作用の予防方法またはそれに用いる薬剤の製造方法
Ziboh et al. γ-linolenic acid-containing diet attenuates bleomycin-induced lung fibrosis in hamsters
Hagve et al. Regulation of the metabolism of polyunsaturated fatty acids
Tamargo et al. Pharmacokinetics and safety profile of omega-3 polyunsaturated fatty acids
Bryan et al. Incorporation of α‐linolenic acid and linoleic acid into human respiratory epithelial cell lines
Becker et al. Incorporation of 14C into tissue lipids after oral administration of [1-14C] linoleic acid in rats fed different levels of essential fatty acids
US7687544B2 (en) Method of using catalpic acid to treat type 2 diabetes and associated disorders
JP5046926B2 (ja) 炎症性疾患予防又は治療剤
Ney et al. Rapid induction of essential fatty acid deficiency by intragastric infusion of triolein-supplemented total parenteral nutrition solutions: evidence of increased hepatic cholesterol esterification in the rat
Robbins et al. γ-Linolenic acid (GLA)-mediated cytotoxicity in human prostate cancer cells